Tracer library / [177Lu]Lu-SibuDAB

[177Lu]Lu-SibuDAB

Also written as [Lu-177]Lu-SibuDAB
Radionuclide
Lu-177 t½ 9584.6 min
Modality
Therapy
Production route
—
Stage
—
Syntheses indexed
0
Prostate cancerDosimetry and biodistribution studiesPSMA-directed radioligand therapy

What it is

Compound class
PSMA-targeting small-molecule ligand with albumin-binding moiety
Target / mechanism
Prostate-specific membrane antigen (PSMA) PMID 39894880
Clinical application
Radioligand therapy of metastatic castration-resistant prostate cancer; dosimetry study PMID 39894880
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [177Lu]Lu-SibuDAB, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 3 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty.
Ask a question